NEW YORK (Reuters Health) – Diabetes is an independent risk factor for atrial fibrillation in women, U.S. investigators report in the October issue of Diabetes Care. The disease…
NEW YORK (Reuters Health) – In older patients with stable coronary disease, adding percutaneous coronary intervention (PCI) to optimal medical therapy neither improves nor worsens their outcomes, new…
NEW YORK (Reuters Health) – Excessive intake of fructose can increase blood pressure and induce other features of the metabolic syndrome, according to study findings presented Wednesday at…
NEW YORK (Reuters Health) – Amlodipine-based therapy is still a better treatment for uncomplicated hypertension than atenolol-based therapy, even in patients with higher baseline heart rates, according to…
NEW YORK (Reuters Health) – Darusentan, a selective endothelin-receptor blocker, can reduce blood pressure in patients who have not reached their target levels using three or more antihypertensive…
NEW YORK (Reuters Health) – Thiazolidinedione treatment of diabetes in older adults is associated with an increased fracture risk, according to a report in the August issue of…
NEW YORK (Reuters Health) – When metformin and a sulphonylurea or a glinide fail to bring type 2 diabetes under control, adding pioglitazone may do the trick, French…
NEW YORK (Reuters Health) – Giving low-dose dopamine to brain-dead donors can improve graft function after kidney transplantation, according to trial findings reported in the Journal of the…
NEW YORK (Reuters Health) – Treatment with fluvastatin both before and after vascular surgery decreases the incidence of cardiovascular death and myocardial infarction, according to results of a…
NEW YORK (Reuters Health) – A long-term trial has shown “no evidence to support the use of endovascular treatment” for carotid artery stenosis over endarterectomy in patients who…
